dehydration and semaglutide Ozempic (Semaglutide): GLP-1 receptor agonist used for type 2 diabetes. It commonly causes dose-related gastrointestinal Generic Weight Loss Medicines in

medRxiv 2026, IQVIA PharMetrics cohort (n=20,504 non-diabetic weight-loss users), incident allodynia 35 vs 15 per 1,000 person-years against bupropion-naltrexone, adjusted HR 2.15 (95% CI 1.572.96)

(Equinox declined to share numbers, but confirmed that expectations were calculated based on budgets from the history of other new market openings.) There are 40 additional locations in the pipeline, with the view of opening about 10 locations per year (Chicagos West Loop, San Diego, Nashville and a second Santa Monica outpost are all on deck for the coming months), as well as a Saudi Arabia Equinox Hotel on the way for spring 2026

The most notable are nausea and mild digestion discomfort issues

Plans are bespoke